Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy.

[1]  L. Habel,et al.  Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Vaidya,et al.  Erratum: Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial (Lancet (2014) 383 (603-613)) , 2014 .

[3]  L. Esserman,et al.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial , 2014, The Lancet.

[4]  D. Heron,et al.  Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity. , 2014, International journal of radiation oncology, biology, physics.

[5]  A. Luini,et al.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. , 2013, The Lancet. Oncology.

[6]  V. Bini,et al.  Outcome of a phase II prospective study on partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  T. Major,et al.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Rakesh R. Patel,et al.  Locoregional Recurrence Following Accelerated Partial Breast Irradiation for Early-Stage Invasive Breast Cancer: Significance of Estrogen Receptor Status and Other Pathological Variables , 2013, Annals of Surgical Oncology.

[9]  Phoebe E. Freer,et al.  Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. , 2012, International journal of radiation oncology, biology, physics.

[10]  R. Sarin,et al.  Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Phoebe E. Freer,et al.  Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. , 2012, International journal of radiation oncology, biology, physics.

[12]  W. Curran,et al.  OT2-06-02: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413. , 2011 .

[13]  R. Sarin,et al.  5125 POSTER Five Year Clinical Outcome in 109 Women With Clinically Palpable Tumours (1-3 cm) Treated With Accelerated Partial Breast Irradiation Using Interstitial Brachytherapy , 2011 .

[14]  T. Major,et al.  Dosimetric characteristics of accelerated partial breast irradiation with CT image--based multicatheter interstitial brachytherapy: a single institution's experience. , 2011, Brachytherapy.

[15]  F. Vicini,et al.  Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  M. Bani,et al.  Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. , 2011, International journal of radiation oncology, biology, physics.

[17]  J. Haviland,et al.  Intraoperative radiotherapy for early breast cancer , 2010, The Lancet.

[18]  A. Luini,et al.  Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons , 2010, Breast Cancer Research and Treatment.

[19]  G. Németh,et al.  Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  R. Pötter,et al.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  F. Vicini,et al.  Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. , 2008, International journal of radiation oncology, biology, physics.

[22]  T. Julian,et al.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, International journal of radiation oncology, biology, physics.

[23]  F. Vicini,et al.  Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. , 2009, International journal of radiation oncology, biology, physics.

[24]  Barbara L. Smith,et al.  Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.

[26]  J R Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.

[27]  Rakesh R. Patel,et al.  Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. , 2008, International journal of radiation oncology, biology, physics.

[28]  A. Munshi,et al.  Dosimetric comparison of conventional radiograph- and three-dimensional computed tomography-based planning using dose volume indices for partial breast intraoperative implants. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[29]  F. Vicini,et al.  Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. , 2007, International journal of radiation oncology, biology, physics.

[30]  R. Pötter,et al.  Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  R. Sarin,et al.  Safety and feasibility of breast conserving therapy in Indian women: Two decades of experience at Tata Memorial Hospital , 2006, Journal of surgical oncology.

[32]  R. M. Wilenzick,et al.  Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. , 2006, International journal of radiation oncology, biology, physics.

[33]  F. Vicini,et al.  Long‐term cosmetic results and toxicity after accelerated partial‐breast irradiation , 2006, Cancer.

[34]  D. Wazer,et al.  Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. , 2006, International journal of radiation oncology, biology, physics.

[35]  D. Todor,et al.  CT-guided multi-catheter insertion technique for partial breast brachytherapy: reliable target coverage and dose homogeneity. , 2005, Brachytherapy.

[36]  Rakesh Patel,et al.  3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance. , 2004, International journal of radiation oncology, biology, physics.

[37]  R. Sarin,et al.  Intraoperative high-dose-rate 192Ir radical implant in early breast cancer: a quality assurance and dosimetry study. , 2003, International journal of radiation oncology, biology, physics.

[38]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[39]  Richard F. Mould,et al.  Brachytherapy from radium to optimization , 1994 .

[40]  S Hellman,et al.  Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. , 1979, International journal of radiation oncology, biology, physics.